News & Analysis on Clinical Trial Services & Contract Research And Development
Affymetrix has signed an agreement to acquire ParAllele Bioscience - a move intended to broaden its variety of microarray applications. This acquisition builds on a two-year collaboration between the two companies.
Targepeutics has announced the issuance of a patent that targets brain cancer compounds, specifically used to treat malignant glioma. The more specific targeting should allow broader and safer application of recombinant cytotoxins.
UK dosage form specialist BioProgress gave the first insight into its much-anticipated strategic review yesterday, just over a month after the departure of former CEO Graham Hind, reports Phil Taylor.
US-based Avery Dennison is now producing radio frequency identification (RFID) inlays using a new high-speed manufacturing process to meet what the company believes will be a booming demand for clients who ship cartons and pallets.
US generic company Alpharma has turned to an Indian company to supply its finished products and active pharmaceutical ingredients, saying that this could cut its costs in half, reports Phil Taylor.
Bruker Daltonics introduces a novel protein post translational modification (PTM) discovery tool that represents the first commercially available Electron Transfer Dissociation (ETD) module for PTM discovery and de novo peptide sequencing on...
SupplyScape, a US company specialising in developing track and trace technologies for the pharmaceutical industry, has teamed up with IT consultancy UniSys to set up a pilot study of SupplyScape's electronic pedigree for drugs, reports Phil Taylor.